G蛋白结合受体信号传输:癌症治疗方面的影响和治疗发展进展
Inamu Rashid Khan1, Sana Khurshid2, Saud Almawash3
1Department of Zoology Central University of Kashmir Ganderbal Kashmir India.
MedComm
|September 19, 2025
概括
G蛋白结合受体 (GPCR) 是癌症中关键的膜蛋白. 了解它们复杂的信号通路,特别是偏差信号,对于开发向癌症疗法至关重要.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- G蛋白结合受体 (GPCR) 是一大类介导细胞反应的膜蛋白.
- GPCRs调节重要的生理功能,并与包括癌症在内的各种疾病有关.
- 瘤中的异常GPCR信号通过影响免疫逃避,增殖和治疗耐药性来促进癌症发生.
研究的目的:
- 审查GPCRs的复杂性及其在癌症信号传递中的作用.
- 专注于G蛋白和β-arrestin的差异性通路激活.
- 探索针对癌症治疗的GPCR信号的向调制.
主要方法:
- 对GPCR结构功能关系的文献综述.
- 对GPCR偏差信号机制的分析.
- 检查用于GPCR向的新兴技术.
主要成果:
- 七个跨膜结构的GPCR促进了多样化的信号网络.
- 特定途径的GPCR激活和偏向的连接体发现是关键的研究领域.
- 针对GPCR信号通路的向调节显示了癌症的治疗潜力.
结论:
- 了解GPCR偏差信号提供了对癌症生物学的见解.
- 新兴的技术,如aptamers,PROTACs和纳米体,可以实现精确的GPCR向.
- 调节GPCR信号通路可能会导致更有效的癌症疗法.
相关概念视频
G Protein-coupled Receptors
16.6K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.6K
Amplifying Signals via Enzymatic Cascade
17.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.5K
Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Transducer Mechanism: G Protein–Coupled Receptors
4.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
4.0K


